Table of Contents Author Guidelines Submit a Manuscript
International Journal of Cell Biology
Volume 2009, Article ID 273651, 8 pages
http://dx.doi.org/10.1155/2009/273651
Research Article

The Response of Creatine Kinase Specific Activity in Rat Pituitary to Estrogenic Compounds and Vitamin D Less-Calcemic Analogs

1Institute of Endocrinology, Metabolism and Hypertension, Sourasky Medical Center, Tel-Aviv 64239, Israel
2The Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 64239, Israel
3Faculty of Science, University of Haifa, Har-Hacarmel, Haifa 31905, Israel
4Laboratory of Natural Compounds for Medical Use, Migal-Galilee Technological Center, Kiryat- Shmona 10200, Israel
5Department of Chemistry, The Johns Hopkins University, Baltimore, MD 21218, USA

Received 20 April 2009; Accepted 24 June 2009

Academic Editor: Gary S. Stein

Copyright © 2009 D. Somjen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Fink, “Gonadotropin secretion and its control,” in The Physiology of Reproduction, E. Knobil and J. Neill, Eds., pp. 1349–1377, Raven Press, New York, NY, USA, 1988. View at Google Scholar
  2. N. A. Mitchner, C. Garlick, and N. Ben-Jonathan, “Cellular distribution and gene regulation of estrogen receptors α and β in the rat pituitary gland,” Endocrinology, vol. 139, no. 9, pp. 3976–3983, 1998. View at Publisher · View at Google Scholar
  3. M. Bottner, J. Christoffel, H. Jarry, and W. Wuttke, “Effects of long-term treatment with revestratrol and subcutaneous and oral estradiol administration on pituitary function in rats,” Journal of Endocrinology, vol. 189, pp. 77–88, 2006. View at Google Scholar
  4. W. Mazur, “Phytoestrogen content in foods,” Bailliers Clinical Endocrinology and Metabolism, vol. 12, no. 4, pp. 729–742, 1998. View at Publisher · View at Google Scholar
  5. D. M. Tham, C. D. Gardner, and W. L. Haskell, “Potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological, and mechanistic evidence,” The Journal of Clinical Endocrinology & Metabolism, vol. 83, no. 7, pp. 2223–2235, 1998. View at Publisher · View at Google Scholar
  6. L. W. Wroblewski Lissin and J. P. Cooke, “Phytoestrogens and cardiovascular health,” Journal of the American College of Cardiology, vol. 35, no. 6, pp. 1403–1410, 2000. View at Publisher · View at Google Scholar
  7. S. Kapiotis, M. Hermann, and I. Held, “Genistein the dietary-derived angiogenesis inhibitor prevents LDL oxidation and protects endothelial cells from damage by atherogenic LDL,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 17, no. 11, pp. 2868–2874, 1997. View at Google Scholar
  8. M. B. Ruiz-Larrla, A. R. Mohan, and G. Paganga, “Antioxidant activity of phytoestrogenic isoflavones,” Free Radical Research, vol. 26, no. 1, pp. 63–70, 1997. View at Google Scholar
  9. E. K. Honore, J. K. Williams, M. S. Anthony, and T. B. Clarkson, “Soy isoflavones enhance coronary vascular reactivity in atherosclerotic female macaques,” Fertility and Sterility, vol. 67, no. 1, pp. 148–154, 1997. View at Publisher · View at Google Scholar
  10. K. L. Britt, E. R. Simpson, and J. K. Findlay, “Effects of phytoestrogens on the ovarian and pituitary phenotypes of estrogen-deficient female aromatase knockout mice,” Menopause, vol. 12, no. 2, pp. 174–185, 2005. View at Publisher · View at Google Scholar
  11. S. Tamir, M. Eizenberg, D. Somjen, S. Izrael, and J. Vaya, “Estrogen-like activity of glabrene and other constituents isolated from licorice root,” Journal of Steroid Biochemistry and Molecular Biology, vol. 78, no. 3, pp. 291–298, 2001. View at Publisher · View at Google Scholar
  12. S. Tamir, M. Eizenberg, D. Somjen et al., “Estrogenic and antiproliferative properties of glabridin from licorice in human breast cancer cells,” Cancer Research, vol. 60, no. 20, pp. 5704–5709, 2000. View at Google Scholar
  13. E. D. Lephart, T. W. West, K. S. Weber et al., “Neurobehavioral effects of dietary soy phytoestrogens,” Neurotoxicology and Teratology, vol. 24, no. 1, pp. 5–16, 2002. View at Publisher · View at Google Scholar
  14. G. F. Jirikowski, U. W. Kauntzer, A. E. E. Dief, and J. K. Caldwell, “Distribution of vitamin D binding protein expressing neurons in the rat hypothalamus,” Biochemistry and Cell Biology, vol. 131, pp. 365–370, 2009. View at Publisher · View at Google Scholar
  15. K. Prufer and G. F. Jirikowski, “1,25-Dihydroxyvitamin D3 receptor is partly colocalized with oxytocin immunoreactivity in neurons of the male rat hypothalamus,” Cellular and Molecular Biology, vol. 43, no. 4, pp. 543–548, 1997. View at Google Scholar
  16. R. Perez-Fernandez, M. Alonso, C. Segura, I. Munoz, T. Garcia-Caballero, and C. Dieguez, “Vitamin D receptor gene expression in human pituitary gland,” Life Sciences, vol. 60, no. 1, pp. 35–42, 1997. View at Publisher · View at Google Scholar
  17. W. E. Stumpf, M. Sar, Y. Reid, Y. Tanaka, and H. F. DeLuca, “Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid,” Science, vol. 206, no. 4423, pp. 1188–1190, 1979. View at Google Scholar
  18. L. P. Freedman, “Anatomy of the steroid receptor zinc finger region,” Endocrine Reviews, vol. 13, no. 2, pp. 129–145, 1992. View at Publisher · View at Google Scholar
  19. J. D. Wark and A. H. Tashijian Jr., “Regulation of prolactin mRNA by 1,25-dihydroxyvitamin D3 in GH4C1 cells,” Journal of Biological Chemistry, vol. 258, no. 20, pp. 12118–12121, 1983. View at Google Scholar
  20. P. Tinnanooru, V. H. Dang, T. H. Nguyen, G. S. Lee, K. C. Choi, and E. B. Jeung, “Estrogen regulates the localization and expression of calbindin D9k in the pituitary gland of immature male rats via ERa-pathway,” Molecular and Cellular Endocrinology, vol. 285, pp. 26–33, 2008. View at Google Scholar
  21. R. H. Wasserman and C. S. Fullmer, “On the molecular mechanism of intestinal calcium transport,” Advances in Experimental Medicine and Biology, vol. 249, pp. 45–65, 1989. View at Google Scholar
  22. N. A. Reiss and A. M. Kaye, “Identification of the major component of the estrogen-induced protein of rat uterus as the BB isozyme of creatine kinase,” Journal of Biological Chemistry, vol. 256, no. 11, pp. 5741–5749, 1981. View at Google Scholar
  23. D. Somjen, M. Shen, N. Stern, and N. Mirsky, “Diabetes modulates differentially creatine kinase-specific activity responsiveness to estradiol-17β and to raloxifene in rat organs,” Journal of Cellular Biochemistry, vol. 99, no. 1, pp. 133–139, 2006. View at Publisher · View at Google Scholar
  24. Y. Amir-Zaltsman, O. Mazor, B. Gayer, A. Scherz, Y. Salomon, and F. Kohen, “Inhibitors of protein tyrosine phosphorylation: preliminary assessment of activity by time-resolved fluorescence,” Luminescence, vol. 15, no. 6, pp. 377–380, 2000. View at Google Scholar
  25. D. Somjen, F. Kohen, B. Gayer et al., “A non-calcemic Vitamin D analog modulates both nuclear and putative membranal estrogen receptors in cultured human vascular smooth muscle cells,” Journal of Steroid Biochemistry and Molecular Biology, vol. 89-90, pp. 397–399, 2004. View at Publisher · View at Google Scholar
  26. P. A. Belinky, M. Aviram, S. Mahmood, and J. Vaya, “Structural aspects of the inhibitory effect of glabridin on LDL oxidation,” Free Radical Biology and Medicine, vol. 24, no. 9, pp. 1419–1429, 1998. View at Publisher · View at Google Scholar
  27. S. Tamir, M. Eizenberg, D. Somjen, S. Izrael, and J. Vaya, “Estrogen-like activity of glabrene and other constituents isolated from licorice root,” Journal of Steroid Biochemistry and Molecular Biology, vol. 78, no. 3, pp. 291–298, 2001. View at Publisher · View at Google Scholar
  28. G. H. Posner, H. B. Jeon, A. Sarjeant et al., “Low-calcemic, efficacious, 1a,25-dihydroxyvitamin D3 analog QW-1624F2-2: calcemic dose-response determination, preclinical genotoxicity testing, and revision of A-ring stereochemistry,” Steroids, vol. 69, no. 11-12, pp. 757–762, 2004. View at Publisher · View at Google Scholar
  29. S. Katzburg, D. Hendel, A. Waisman, G. H. Posner, A. M. Kaye, and D. Somjen, “Treatment with non-hypercalcemic analogs of 1,25-dihydroxyvitamin D 3 increases responsiveness to 17β-estradiol, dihydrotestosterone or raloxifene in primary human osteoblasts,” Journal of Steroid Biochemistry and Molecular Biology, vol. 88, no. 2, pp. 213–219, 2004. View at Publisher · View at Google Scholar
  30. D. Somjen, A. Harell, N. Jaccard, Y. Weisman, and A. M. Kaye, “Reciprocal modulation by sex steroid and calciotrophic hormones of skeletal cell proliferation,” Journal of Steroid Biochemistry and Molecular Biology, vol. 37, no. 4, pp. 491–499, 1990. View at Publisher · View at Google Scholar
  31. D. Somjen, E. Knoll, J. Vaya, N. Stern, and S. Tamir, “Estrogen-like activity of licorice root constituents: glabridin and glabrene, in vascular tissues in vitro and in vivo,” Journal of Steroid Biochemistry and Molecular Biology, vol. 91, no. 3, pp. 147–155, 2004. View at Publisher · View at Google Scholar
  32. D. Somjen, Y. Amir-Zaltsman, B. Gayer et al., “6-carboxymethyl genistein: a novel selective oestrogen receptor modulator (SERM) with unique, differential effects on the vasculature, bone and uterus,” Journal of Endocrinology, vol. 173, no. 3, pp. 415–427, 2002. View at Publisher · View at Google Scholar
  33. J. E. Sanchez-Criado, J. M. de Las Mulas, C. Bellido, M. Tena-Sempere, R. Aguilar, and A. Blanco, “Biological role of pituitary estrogen receptors ERα and ERβ on progesterone receptor expression and action and on gonadotropin and prolactin secretion in the rat,” Neuroendocrinology, vol. 79, no. 5, pp. 247–258, 2004. View at Publisher · View at Google Scholar
  34. M. R. Haussler, S. C. Manolagas, and L. J. Deftos, “Receptor for 1,25-dihydroxyvitamin D3 in GH3 pituitary cells,” Journal of Steroid Biochemistry, vol. 16, no. 1, pp. 15–19, 1982. View at Publisher · View at Google Scholar
  35. R. Perez-Fernandez, M. Alonso, C. Segura, I. Munoz, T. Garcia-Cabarello, and C. Dieguez, “Vitamin D gene expression in human pituitary gland,” Life Sciences, vol. 60, pp. 35–42, 1997. View at Google Scholar
  36. K. Törnquist and C. Lamberg-Allardt, “Effect of 1, 25(OH)2D3 on the TSH secretion from rat pituitary cells,” Hormone and Metabolic Research, vol. 18, p. 69, 1986. View at Google Scholar
  37. T. H. Nguyen, G.-S. Lee, Y.-K. Ji, K.-C. Choi, C.-K. Lee, and E.-B. Jeung, “A calcium binding protein, calbindin-D9k, is mainly regulated by estrogen in the pituitary gland of rats during estrous cycle,” Molecular Brain Research, vol. 141, no. 2, pp. 166–173, 2005. View at Publisher · View at Google Scholar
  38. P. Tinnanooru, V. H. Dang, T. H. Nguyen, G.-S. Lee, K.-C. Choi, and E.-B. Jeung, “Estrogen regulates the localization and expression of calbindin-D9k in the pituitary gland of immature male rats via the ERα-pathway,” Molecular and Cellular Endocrinology, vol. 285, no. 1-2, pp. 26–33, 2008. View at Publisher · View at Google Scholar